Umut Gokhan, Evren Cuneyt, Atagun Murat Ilhan, Hisim Ozge, Yilmaz Cengel Hanife, Bozkurt Muge, Keskinkilic Cahit
Research, Treatment and Training Center for Alcohol and Substance Dependence (AMATEM), Bakirkoy Training and Research Hospital for Psychiatry Neurology and Neurosurgery, Istanbul, Turkey.
Department of Psychiatry, Medicine Faculty, Yildirim Beyazit University, Ankara, Turkey.
Cannabis Cannabinoid Res. 2020 Jun 5;5(2):164-171. doi: 10.1089/can.2019.0017. eCollection 2020 Jun 1.
Synthetic cannabinoid (SC) use, an important public health problem, is becoming increasingly widespread and leads to many medical and psychiatric problems. This study aimed to evaluate the impact of SC use on cognitive and psychomotor functions of patients. The participants (30 outpatients with SC use disorder and 33 healthy controls) were administered the Montreal Cognitive Assessment (MOCA) test, the Edinburgh Handedness Inventory (EHI), the Finger-Tapping Test (FTT), and the Adult Memory and Information Processing Battery-B form (AMIPB-B). The SC users scored lower in AMIPB-B, MOCA. and FTT compared to the healthy controls. These findings suggest that SC might impair both cognitive and psychomotor functions. Therefore, outpatients with SC use disorder should be carefully evaluated for cognitive and psychomotor functions since neurological examinations and interventions may also be required in treatment programs for these cases.
合成大麻素(SC)的使用是一个重要的公共卫生问题,且日益普遍,并导致诸多医学和精神问题。本研究旨在评估使用SC对患者认知和心理运动功能的影响。参与者(30名患有SC使用障碍的门诊患者和33名健康对照者)接受了蒙特利尔认知评估(MOCA)测试、爱丁堡利手量表(EHI)、手指敲击测试(FTT)以及成人记忆与信息处理成套测验-B型(AMIPB-B)。与健康对照者相比,使用SC的患者在AMIPB-B、MOCA和FTT测试中的得分较低。这些发现表明,SC可能损害认知和心理运动功能。因此,对于患有SC使用障碍的门诊患者,应仔细评估其认知和心理运动功能,因为在这些病例的治疗方案中可能还需要进行神经学检查和干预。